About apc

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

Review Article 
Liquid biopsy and biomarkers in pancreatic ductal adenocarcinoma: from concept to clinical translation—a narrative review
Sara Mahmoud Ibrahim Allaham, Shamsul Mustafa Mohamed Ridha Alsaraf, Manal Faraj Yusuf, Yasamin Alsadat Sohrevardi, Abdifatah Fozi Hadji Abdillahi
Annals of Pancreatic Cancer  
2026;
9:
16
.
Editorial Commentary 
Can preoperative radiotherapy reduce the risk of postoperative pancreatic fistula after pancreatoduodenectomy?
Shahin Hajibandeh, Robert P. Sutcliffe
Annals of Pancreatic Cancer  
2026;
9:
15
.
Editorial Commentary 
Comparing neoadjuvant regimens in resectable and borderline resectable pancreatic cancer: lessons from PREOPANC-2
Maria Fernanda Teixeira, Pedro Luiz Serrano Uson Junior
Annals of Pancreatic Cancer  
2026;
9:
14
.
Editorial Commentary 
CDK4/6 inhibition in pancreatic cancer: lessons learned as the therapeutic landscape evolves
Shreyas Kalantri, Brandon Smaglo
Annals of Pancreatic Cancer  
2026;
9:
13
.
Editorial Commentary 
PASS-01: the final step on the journey towards the optimal chemotherapy regimen for metastatic pancreatic adenocarcinoma?
Victor Hugo Fonseca de Jesus, Alexandre Jácome
Annals of Pancreatic Cancer  
2026;
9:
11
.
Editorial Commentary 
Perioperative therapy to control hepatic micrometastases in pancreatic ductal adenocarcinoma: an appraisal of the TOSPAC-02 study
Omar Mahmud, Asad Saulat Fatimi, Andrew Rosowicz, Ammar A. Javed
Annals of Pancreatic Cancer  
2026;
9:
10
.
Editorial Commentary 
The evolving neoadjuvant landscape in pancreatic cancer: biology often overrides anatomy in achieving margin-negative resection
Betty T. Chang, Shreeja N. Patel, Joseph R. Habib, Michael D. Kluger
Annals of Pancreatic Cancer  
2026;
9:
9
.
Editorial Commentary 
Stereotactic body radiotherapy in pancreatic ductal adenocarcinoma: interpreting the results of the SPAN-C trial
Jacobien C. M. Scheepens, Guus Grimbergen, Lois A. Daamen
Annals of Pancreatic Cancer  
2026;
9:
8
.
Letter to the Editor 
Improving long-term outcomes in resectable pancreatic cancer
John P. Neoptolemos, Christoph Springfeld, Thilo Hackert, Daniel H. Palmer, Daniel Öhlund, Teresa Peccerella, Jonathan M. Harnoss, Thomas Hank, Francesco Ladisa, Christoph W. Michalski
Annals of Pancreatic Cancer  
2026;
9:
6
.
Original Article 
Estimation of symptoms burden in advanced pancreatic cancer patient and impact of palliative care intervention on it
Savan Kukadia, Ravi Umrania, Bhavna Patel, Priti Sanghavi, Vasundhara Sharma, Vrinda Satija
Annals of Pancreatic Cancer  
2026;
9:
5
.
Editorial Commentary 
Optimal management of resectable pancreatic ductal adenocarcinoma
Yongwoo David Seo, Mandana Kamgar
Annals of Pancreatic Cancer  
2026;
9:
4
.
Letter to the Editor 
FOLFIRINOX for pancreatic cancer: a real-world registry analysis
Shameer Tahir
Annals of Pancreatic Cancer  
2026;
9:
3
.
Editorial Commentary 
Defining risk-adapted adjuvant therapy in resectable pancreatic cancer: an editorial commentary on long-term outcomes from ESPAC4
Elizabeth S. Nakasone, Andrew L. Coveler
Annals of Pancreatic Cancer  
2026;
9:
2
.
Editorial Commentary 
Insights from the NEOPAN trial: FOLFIRINOX vs. gemcitabine in locally advanced pancreatic cancer
Ronan Andrew McLaughlin, Jennifer Jane Knox
Annals of Pancreatic Cancer  
2025;
8:
15
.
Case Report 
Pancreatic adenocarcinoma with metastasis to cervix: a case report of an unusual neoplastic demeanor
Saarthak Miglani, Tanshi Daljit, Savita Arora, Surbhi Goyal, Arun Kumar Rathi
Annals of Pancreatic Cancer  
2025;
8:
14
.
Original Article 
Efficacy and toxicity of gemcitabine plus nab-paclitaxel in patients with metastatic pancreatic adenocarcinoma after disease progression on FOLFIRINOX: a single-center analysis
Marcos Pedro Guedes Camandaroba, Francisco de Assis Maia Jr, Cícero Gonzaga Santos, Tiago Cordeiro Felismino, Victor Hugo Fonseca de Jesus
Annals of Pancreatic Cancer  
2025;
8:
13
.
Original Article 
Modified FOLFIRINOX as the first-line chemotherapy in unresectable and metastatic pancreatic adenocarcinoma—a single-center experience in India
Satyajeet Soni, Arpit Jain, Varun Goyal, Satya Narayan, Pallavi Redhu, Pankaj Goyal, Shiva Shankara Swamy, Vineet Talwar
Published online: 15 November 2023
Review Article
 
Multifunctional role of pancreatic stellate cells in pancreatic cancer
Alpha R. Mekapogu, Srinivasa P. Pothula, Romano C. Pirola, Jeremy S. Wilson, Minoti V. Apte
Published online: 12 June 2019
Original Article 
Effects of treatment delays on outcomes in pancreatic adenocarcinoma
Calvin X. Geng, Anuragh R. Gudur, Laura B. Lavette, Ross C. D. Buerlein, Daniel S. Strand, Vanessa M. Shami, Andrew Y. Wang, Matthew J. Reilley, Alexander Podboy
Published online: 20 September 2024
Review Article
 
Preclinical mouse models for immunotherapeutic and non-immunotherapeutic drug development for pancreatic ductal adenocarcinoma
Mengni He, MacKenzie Henderson, Stephen Muth, Adrian Murphy, Lei Zheng
Published online: 22 July 2020
Review Article
 
Genetics and biology of pancreatic cancer and its precursor lesions: lessons learned from human pathology and mouse models
Motoyuki Tsuda, Akihisa Fukuda, Kyoichi Takaori, Hiroshi Seno
Published online: 22 August 2019
Review Article
 
Cellular crosstalk mediating immune evasion in pancreatic cancer microenvironment
Chenggang Gao, Qiang Shen, Tao Yin
Published online: 19 July 2019
Review Article
 
Targeting the epigenome of pancreatic cancer for therapy: challenges and opportunities
Marina Baretti, Nita Ahuja, Nilofer Saba Azad
Published online: 23 October 2019
Case Report 
Visceral crisis in a patient with pancreatic ductal adenocarcinoma with DPYD and UGT1A1 gene mutations: case report, literature review, and viewpoint
Luxi Chen, Cynthia Mark, Matthew I. Ebia, Anser Abbas, David Oveisi, Suzanne Dotson, Jun Gong, Andrew Hendifar, Arsen Osipov
Published online: 10 October 2024
Review Article
 
Superior mesenteric artery-first approach with laparoscopic pancreaticoduodenectomy
Xu Sun, Jing Mao, Xiaofeng Ni, Qiang Yan
Published online: 19 August 2019
Review Article
 
Adjuvant therapeutic strategies for resectable pancreatic adenocarcinoma
Nikhil Yegya-Raman, Mihir M. Shah, Miral S. Grandhi, Elizabeth Poplin, David A. August, Timothy J. Kennedy, Usha Malhotra, Kristen R. Spencer, Darren R. Carpizo, Salma K. Jabbour
Published online: 07 August 2018
Review Article
 
Insights into the biology and treatment strategies of pancreatic neuroendocrine tumors
Jessica L. Buicko, Brendan M. Finnerty, Tiantian Zhang, Bu Jung Kim, Thomas J. Fahey III, Yi-Chieh Nancy Du
Published online: 20 June 2019
Original Article
Quantitative metric for assessment of pancreatic ductal adenocarcinoma treatment response in T1-weighted gadolinium-enhanced magnetic resonance imaging
Joy Liau, Srinivasan Vedantham, Hani M. Babiker, Travis McGlothin, Diego R. Martin
Original Article
Nonselective β-adrenergic blockade impacts pancreatic cancer tumor biology, decreases perineural invasion and improves patient survival
Alex B. Blair, Noelle R. Jurcak, Ammar Javed, Jonathan Teinor, Vincent P. Groot, Noah Rozich, John L. Cameron, Matthew J. Weiss, Jin He, Christopher L. Wolfgang, Lei Zheng, Richard A. Burkhart
Original Article
Analyzing outcomes of neoadjuvant and adjuvant treatment for borderline-resectable pancreatic adenocarcinoma in the perioperative period at an academic institution
Alejandro Recio-Boiles, Jessica Vondrak, Summana Veeravelli, James J. Mancuso, Kathylynn Saboda, Denise J. Roe, Irbaz Bin Riaz, Aaron J. Scott, Emad Elquza, Ali McBride, Hani M. Babiker
Original Article
Adding combination immunotherapy consisting of cancer vaccine, anti-PD-1 and anti-CSF1R antibodies to gemcitabine improves anti-tumor efficacy in murine model of pancreatic ductal adenocarcinoma
May Tun Saung, Lei Zheng
Original Article
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios inversely correlate to clinical and pathologic stage in patients with resectable pancreatic ductal adenocarcinoma
Alejandro Recio-Boiles, Aparna Nallagangula, Summana Veeravelli, Jessica Vondrak, Kathylynn Saboda, Denise Roe, Emad Elquza, Ali McBride, Hani M. Babiker
Review Article

Modeling human pancreatic ductal adenocarcinoma for translational research: current options, challenges, and prospective directions
Reecha Suri, Jacquelyn W. Zimmerman, Richard A. Burkhart
Review Article

Preclinical mouse models for immunotherapeutic and non-immunotherapeutic drug development for pancreatic ductal adenocarcinoma
Mengni He, MacKenzie Henderson, Stephen Muth, Adrian Murphy, Lei Zheng
Review Article

Targeting homologous recombination addicted tumors: challenges and opportunities
Talia Golan, Jonathan R. Brody
Review Article

Evolving trends in pancreatic cancer therapeutic development
Imani Bijou, Jin Wang
Review Article

Insights into the biology and treatment strategies of pancreatic neuroendocrine tumors
Jessica L. Buicko, Brendan M. Finnerty, Tiantian Zhang, Bu Jung Kim, Thomas J. Fahey III, Yi-Chieh Nancy Du
Review Article

Ductal vs. acinar? Recent insights into identifying cell lineage of pancreatic ductal adenocarcinoma
Yi Xu, Jun Liu, Michael Nipper, Pei Wang
Review Article

Malnutrition, frailty, and sarcopenia in pancreatic cancer patients: assessments and interventions for the pancreatic surgeon
Noah S. Rozich, Caitlin E. Jones, Katherine T. Morris
Review Article

Altering the response to radiation: radiosensitizers and targeted therapies in pancreatic ductal adenocarcinoma: preclinical and emerging clinical evidence
Adam R. Wolfe, Terence M. Williams
Review Article

Current and emerging radiotherapy strategies for pancreatic adenocarcinoma: stereotactic, intensity modulated and particle radiotherapy
Sweet Ping Ng, Eugene J. Koay
Review Article

Adjuvant therapeutic strategies for resectable pancreatic adenocarcinoma
Nikhil Yegya-Raman, Mihir M. Shah, Miral S. Grandhi, Elizabeth Poplin, David A. August, Timothy J. Kennedy, Usha Malhotra, Kristen R. Spencer, Darren R. Carpizo, Salma K. Jabbour
Review Article

Robotic distal pancreatectomy: greatest benefit for the frail?
Ioannis T. Konstantinidis, Laleh G. Melstrom
Perspective

Immune defects in pancreatic cancer
Lei Zheng